White label – Pompe disease - ClinicalTrials.eu

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

Not recruiting

3 1 1
Investigated Diseases:
- Systemic lupus erythematosus
Investigated Drugs:
- Deucravacitinib
+2
Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

Not recruiting

2 1 1 1
Investigated Diseases:
- Ovarian epithelial cancer
- Fallopian tube cancer
Investigated Drugs:
Study on the Effect of DA-EPOCH-R and Nivolumab in Patients with Newly Diagnosed High-Grade B-Cell Lymphoma with MYC and BCL2/BCL6 Rearrangements

Not recruiting

2 1 1 1
Investigated Diseases:
- High-grade B-cell lymphoma
Investigated Drugs:
Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Not recruiting

3 1
Investigated Diseases:
- Heart failure with reduced ejection fraction
Investigated Drugs:
- Vericiguat
+6
Study on the Effectiveness of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Treatment Failure

Not recruiting

2 1 1 1
Investigated Diseases:
- Myelodysplastic syndrome
- Acute myeloid leukaemia
Investigated Drugs:
Study of Zilovertamab Vedotin with Drug Combination for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Not recruiting

4 1 1 1
Investigated Drugs:
Study on Avibactam and Drug Combination for Treating Severe Infections in Patients

Not recruiting

3 1 1 1
Investigated Diseases:
- Sepsis
Investigated Drugs:
Study of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
- Pembrolizumab
+7
Study Comparing Nivolumab with Ipilimumab or Nivolumab with Chemotherapy to Chemotherapy Alone in Patients with Early Stage Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
Study on the Effects of Atacicept in Adults with IgA Nephropathy

Not recruiting

4 1 1
Investigated Drugs:
+7

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies